Hepatite C (Portuguese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Hepatite C" in Portuguese language version.

refsWebsite

Global rank Portuguese rank

68nih.gov

4^th place

8^th place

57doi.org

2^nd place

4^th place

8google.ca

838^th place

320^th place

5wiley.com

222^nd place

196^th place

4cdc.gov

218^th place

177^th place

2who.int

195^th place

150^th place

2aafp.org

1,916^th place

2,712^th place

2wjgnet.com

low place

2oxfordjournals.org

1,389^th place

585^th place

2web.archive.org

1^st place

1casemedicine.com

low place

1worldcat.org

5^th place

1journal-of-hepatology.eu

low place

1springerlink.com

2,569^th place

1,373^rd place

1albawaba.com

3,528^th place

low place

1va.gov

4,581^st place

5,313^th place

1natap.org

low place

1expert-reviews.com

low place

1elsevierhealth.com

low place

1espacenet.com

800^th place

3,230^th place

1georgetown.edu

2,318^th place

2,173^rd place

1eurosurveillance.org

low place

1phac-aspc.gc.ca

low place

aafp.org

Wilkins, T; Malcolm JK; Raina D; Schade RR (1 de junho de 2010). «Hepatitis C: diagnosis and treatment» (PDF). American family physician. 81 (11): 1351–7. PMID 20521755
Lam, NC; Gotsch, PB, Langan, RC (15 de novembro de 2010). «Caring for pregnant women and newborns with hepatitis B or C» (PDF). American family physician. 82 (10): 1225–9. PMID 21121533

albawaba.com

www1.albawaba.com

«Highest Rates of Hepatitis C Virus Transmission Found in Egypt». Al Bawaaba. 9 de agosto de 2010. Consultado em 27 de agosto de 2010

casemedicine.com

Rosen, HR (23 de junho de 2011). «Clinical practice. Chronic hepatitis C infection» (PDF). The New England Journal of Medicine. 364 (25): 2429–38. PMID 21696309. doi:10.1056/NEJMcp1006613

cdc.gov

«Hepatitis C FAQs for Health Professionals». Centers for Disease Control. 8 de janeiro de 2016. Consultado em 4 de fevereiro de 2016
«Hepatitis C» (PDF). Centers for Disease Control and Prevention (CDC). Consultado em 2 de Janeiro de 2012
«Hepatitis C FAQs for Health Professionals». Centers for Disease Control and Prevention (CDC). Consultado em 2 de Janeiro de 2012

wwwnc.cdc.gov

Philip Spradling. «CDC Health Information for International Travel 2012». CDC. Consultado em 3 de junho de 2020

doi.org

dx.doi.org

Maheshwari, A; Thuluvath, PJ (fevereiro de 2010). «Management of acute hepatitis C». Clinics in liver disease. 14 (1): 169–76; x. PMID 20123448. doi:10.1016/j.cld.2009.11.007
Rosen, HR (23 de junho de 2011). «Clinical practice. Chronic hepatitis C infection» (PDF). The New England Journal of Medicine. 364 (25): 2429–38. PMID 21696309. doi:10.1056/NEJMcp1006613
GBD 2015 Disease and Injury Incidence and Prevalence, Collaborators. (8 de outubro de 2016). «Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.». Lancet. 388 (10053): 1545–1602. PMC 5055577. PMID 27733282. doi:10.1016/S0140-6736(16)31678-6
GBD 2015 Mortality and Causes of Death, Collaborators. (8 de outubro de 2016). «Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.». Lancet. 388 (10053): 1459–1544. PMID 27733281. doi:10.1016/S0140-6736(16)31012-1
Webster, Daniel P; Klenerman, Paul; Dusheiko, Geoffrey M (2015). «Hepatitis C». The Lancet. 385 (9973): 1124–1135. ISSN 0140-6736. PMC 4878852. PMID 25687730. doi:10.1016/S0140-6736(14)62401-6
Gravitz L. (2011). «A smouldering public-health crisis». Nature. 474 (7350): S2–4. PMID 21666731. doi:10.1038/474S2a
Mohd Hanafiah, K; Groeger, J; Flaxman, AD; Wiersma, ST (Abril de 2013). «Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence.». Hepatology (Baltimore, Md.). 57 (4): 1333–42. PMID 23172780. doi:10.1002/hep.26141
Global Burden of Disease Study 2013, Collaborators (22 de agosto de 2015). «Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.». Lancet (London, England). 386 (9995): 743–800. PMID 26063472. doi:10.1016/s0140-6736(15)60692-4
GBD 2013 Mortality and Causes of Death, Collaborators (17 de dezembro de 2014). «Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013.». Lancet. 385 (9963): 117–71. PMC 4340604. PMID 25530442. doi:10.1016/S0140-6736(14)61682-2
Houghton M (novembro de 2009). «The long and winding road leading to the identification of the hepatitis C virus». Journal of Hepatology. 51 (5): 939–48. PMID 19781804. doi:10.1016/j.jhep.2009.08.004
Maheshwari, A; Ray S; Thuluvath PJ (26 de julho de 2008). «Acute hepatitis C». Lancet. 372 (9635): 321–32. PMID 18657711. doi:10.1016/S0140-6736(08)61116-2
Nelson, PK; Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, Degenhardt L (13 de agosto de 2011). «Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews». Lancet. 378 (9791): 571–83. PMC 3285467. PMID 21802134. doi:10.1016/S0140-6736(11)61097-0
Mueller, S; Millonig G; Seitz HK (28 de julho de 2009). «Alcoholic liver disease and hepatitis C: a frequently underestimated combination» (PDF). World journal of gastroenterology : WJG. 15 (28): 3462–71. PMC 2715970. PMID 19630099. doi:10.3748/wjg.15.3462 ^{[ligação inativa]}
Ozaras, R; Tahan, V (abril de 2009). «Acute hepatitis C: prevention and treatment». Expert review of anti-infective therapy. 7 (3): 351–61. PMID 19344247. doi:10.1586/eri.09.8
Zignego, AL; Ferri, C; Pileri, SA; et al. (janeiro de 2007). «Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach». Digestive and Liver Disease. 39 (1): 2–17. PMID 16884964. doi:10.1016/j.dld.2006.06.008
Louie, KS; Micallef JM; Pimenta JM; Forssen UM (janeiro de 2011). «Prevalence of thrombocytopenia among patients with chronic hepatitis C: a systematic review». Journal of viral hepatitis. 18 (1): 1–7. PMID 20796208. doi:10.1111/j.1365-2893.2010.01366.x
Lee, MR; Shumack, S (novembro de 2005). «Prurigo nodularis: a review». The Australasian journal of dermatology. 46 (4): 211–18; quiz 219–20. PMID 16197418. doi:10.1111/j.1440-0960.2005.00187.x
Iannuzzella, F; Vaglio, A; Garini, G (maio de 2010). «Management of hepatitis C virus-related mixed cryoglobulinemia». Am. J. Med. 123 (5): 400–8. PMID 20399313. doi:10.1016/j.amjmed.2009.09.038
Sugden, PB; Cameron, B, Bull, R, White, PA, Lloyd, AR (Setembro de 2012). «Occult infection with hepatitis C virus: friend or foe?». Immunology and cell biology. 90 (8): 763–73. PMID 22546735. doi:10.1038/icb.2012.20
Carreño García, V; Nebreda, JB, Aguilar, IC, Quiroga Estévez, JA (Março de 2011). «Occult hepatitis C virus infection.». Enfermedades infecciosas y microbiologia clinica. 29 Suppl 3: 14–9. PMID 21458706. doi:10.1016/S0213-005X(11)70022-2
Pham, TN; Coffin, CS, Michalak, TI (Abril de 2010). «Occult hepatitis C virus infection: what does it mean?». Liver international : official journal of the International Association for the Study of the Liver. 30 (4): 502–11. PMID 20070513. doi:10.1111/j.1478-3231.2009.02193.x
Carreño, V; Bartolomé, J, Castillo, I, Quiroga, JA (21 de junho de 2012). «New perspectives in occult hepatitis C virus infection.». World journal of gastroenterology : WJG. 18 (23): 2887–94. PMID 22736911. doi:10.3748/wjg.v18.i23.2887
Carreño, V; Bartolomé, J; Castillo, I; Quiroga, JA (maio–junho de 2008). «Occult hepatitis B virus and hepatitis C virus infections.». Reviews in medical virology. 18 (3): 139–57. PMID 18265423. doi:10.1002/rmv.569
Scott, JD; Gretch, DR (21 de fevereiro de 2007). «Molecular diagnostics of hepatitis C virus infection: a systematic review.». JAMA: the Journal of the American Medical Association. 297 (7): 724–32. PMID 17312292. doi:10.1001/jama.297.7.724
Nakano, T; Lau, GM; Lau, GM; et al. (dezembro de 2011). «An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region». Liver Int. 32 (2): 339–45. PMID 22142261. doi:10.1111/j.1478-3231.2011.02684.x
Pondé, RA (fevereiro de 2011). «Hidden hazards of HCV transmission» (PDF). Medical microbiology and immunology. 200 (1): 7–11. PMID 20461405. doi:10.1007/s00430-010-0159-9
Xia, X; Luo J, Bai J, Yu R (outubro de 2008). «Epidemiology of HCV infection among injection drug users in China: systematic review and meta-analysis». Public health. 122 (10): 990–1003. PMID 18486955. doi:10.1016/j.puhe.2008.01.014
Imperial, JC (junho de 2010). «Chronic hepatitis C in the state prison system: insights into the problems and possible solutions». Expert review of gastroenterology & hepatology. 4 (3): 355–64. PMID 20528122. doi:10.1586/egh.10.26
Vescio, MF; Longo B, Babudieri S, Starnini G, Carbonara S, Rezza G, Monarca R (abril de 2008). «Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis». Journal of epidemiology and community health. 62 (4): 305–13. PMID 18339822. doi:10.1136/jech.2006.051599
Tohme RA, Holmberg SD (julho de 2010). «Is sexual contact a major mode of hepatitis C virus transmission?». Hepatology. 52 (4): 1497–505. PMID 20635398. doi:10.1002/hep.23808
Jafari, S; Copes R, Baharlou S, Etminan M, Buxton J (novembro de 2010). «Tattooing and the risk of transmission of hepatitis C: a systematic review and meta-analysis» (PDF). International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 14 (11): e928–40. PMID 20678951. doi:10.1016/j.ijid.2010.03.019
Lock G; Dirscherl M; Obermeier F; et al. (setembro de 2006). «Hepatitis C — contamination of toothbrushes: myth or reality?». J. Viral Hepat. 13 (9): 571–3. PMID 16907842. doi:10.1111/j.1365-2893.2006.00735.x
Senadhi, V (julho de 2011). «A paradigm shift in the outpatient approach to liver function tests». Southern Medical Journal. 104 (7): 521–5. PMID 21886053. doi:10.1097/SMJ.0b013e31821e8ff5
Halliday, J; Klenerman P, Barnes E (Maio de 2011). «Vaccination for hepatitis C virus: closing in on an evasive target» (PDF). Expert review of vaccines. 10 (5): 659–72. PMC 3112461. PMID 21604986. doi:10.1586/erv.11.55
Hagan, H; Pouget, ER, Des Jarlais, DC (1 de julho de 2011). «A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs». The Journal of infectious diseases. 204 (1): 74–83. PMC 3105033. PMID 21628661. doi:10.1093/infdis/jir196
Torresi, J; Johnson D, Wedemeyer H (junho de 2011). «Progress in the development of preventive and therapeutic vaccines for hepatitis C virus» (PDF). Journal of hepatology. 54 (6): 1273–85. PMID 21236312. doi:10.1016/j.jhep.2010.09.040
Ilyas, JA; Vierling, JM (agosto de 2011). «An overview of emerging therapies for the treatment of chronic hepatitis C». Clinics in liver disease. 15 (3): 515–36. PMID 21867934. doi:10.1016/j.cld.2011.05.002
Hoofnagle, JH; Sherker, AH (17 de abril de 2014). «Therapy for hepatitis C--the costs of success.». The New England Journal of Medicine. 370 (16): 1552–3. PMID 24725236. doi:10.1056/nejme1401508
Liang, TJ; Ghany, MG (16 de maio de 2013). «Current and future therapies for hepatitis C virus infection.». The New England Journal of Medicine. 368 (20): 1907–17. PMID 23675659. doi:10.1056/NEJMra1213651
Awad T, Thorlund K, Hauser G, Stimac D, Mabrouk M, Gluud C (abril de 2010). «Peginterferon alpha-2a is associated with higher sustained virological response than peginterferon alfa-2b in chronic hepatitis C: systematic review of randomized trials». Hepatology. 51 (4): 1176–84. PMID 20187106. doi:10.1002/hep.23504
Foote BS, Spooner LM, Belliveau PP (setembro de 2011). «Boceprevir: a protease inhibitor for the treatment of chronic hepatitis C». Ann Pharmacother. 45 (9): 1085–93. PMID 21828346. doi:10.1345/aph.1P744
Smith LS, Nelson M, Naik S, Woten J (maio de 2011). «Telaprevir: an NS3/4A protease inhibitor for the treatment of chronic hepatitis C». Ann Pharmacother. 45 (5): 639–48. PMID 21558488. doi:10.1345/aph.1P430
Ghany MG, Nelson DR, Strader DB, Thomas DL, Seeff LB (outubro de 2011). «An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases». Hepatology. 54 (4): 1433–44. PMC 3229841. PMID 21898493. doi:10.1002/hep.24641
Alavian SM, Tabatabaei SV (abril de 2010). «Treatment of chronic hepatitis C in polytransfused thalassaemic patients: a meta-analysis». J. Viral Hepat. 17 (4): 236–44. PMID 19638104. doi:10.1111/j.1365-2893.2009.01170.x
De Clercq, E (15 de novembro de 2013). «Dancing with chemical formulae of antivirals: A panoramic view (Part 2).». Biochemical pharmacology. 86 (10): 1397–410. PMID 24070654. doi:10.1016/j.bcp.2013.09.010
Bunchorntavakul, C; Chavalitdhamrong, D; Tanwandee, T (27 de setembro de 2013). «Hepatitis C genotype 6: A concise review and response-guided therapy proposal.». World journal of hepatology. 5 (9): 496–504. PMID 24073301. doi:10.4254/wjh.v5.i9.496
Ciria R, Pleguezuelo M, Khorsandi SE; et al. (Maio de 2013). «Strategies to reduce hepatitis C virus recurrence after liver transplantation». World J Hepatol. 5 (5): 237–50. PMC 3664282. PMID 23717735. doi:10.4254/wjh.v5.i5.237
Coilly A, Roche B, Samuel D (Fevereiro de 2013). «Current management and perspectives for HCV recurrence after liver transplantation». Liver Int. 33 Supl. 1: 56–62. PMID 23286847. doi:10.1111/liv.12062
Liu, J; Manheimer E, Tsutani K, Gluud C (março de 2003). «Medicinal herbs for hepatitis C virus infection: a Cochrane hepatobiliary systematic review of randomized trials». The American journal of gastroenterology. 98 (3): 538–44. PMID 12650784. doi:10.1111/j.1572-0241.2003.07298.x
Fung J; Lai CL; Hung I; et al. (Setembro de 2008). «Chronic hepatitis C virus genotype 6 infection: response to pegylated interferon and ribavirin». The Journal of Infectious Diseases. 198 (6): 808–12. PMID 18657036. doi:10.1086/591252
Yu ML; Chuang WL (março de 2009). «Treatment of chronic hepatitis C in Asia: when East meets West». J. Gastroenterol. Hepatol. 24 (3): 336–45. PMID 19335784. doi:10.1111/j.1440-1746.2009.05789.x
Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (abril de 1989). «Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome». Science. 244 (4902): 359–62. PMID 2523562. doi:10.1126/science.2523562
Kuo, G; Choo, Q L; Alter, H J; et al. (21 de abril de 1989). «An Assay for Circulating Antibodies to a Major Etiologic Virus of Human non-A, non-B Hepatitis». Science. 244 (4902): 362–4. PMID 2496467. doi:10.1126/science.2496467. Consultado em 3 de junho de 2020
Wong, JB (2006). «Hepatitis C: cost of illness and considerations for the economic evaluation of antiviral therapies». PharmacoEconomics. 24 (7): 661–72. PMID 16802842. doi:10.2165/00019053-200624070-00005
El Khoury, AC; Klimack, WK; Wallace, C; Razavi, H (1 de Dezembro de 2011). «Economic burden of hepatitis C-associated diseases in the United States». Journal of Viral Hepatitis. 19 (3): 153–60. PMID 22329369. doi:10.1111/j.1365-2893.2011.01563.x
Ahn, J; Flamm, SL (agosto de 2011). «Hepatitis C therapy: other players in the game». Clinics in liver disease. 15 (3): 641–56. PMID 21867942. doi:10.1016/j.cld.2011.05.008
Vermehren, J; Sarrazin, C (fevereiro de 2011). «New HCV therapies on the horizon». Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 17 (2): 122–34. PMID 21087349. doi:10.1111/j.1469-0691.2010.03430.x

elsevierhealth.com

download.journals.elsevierhealth.com

Torresi, J; Johnson D, Wedemeyer H (junho de 2011). «Progress in the development of preventive and therapeutic vaccines for hepatitis C virus» (PDF). Journal of hepatology. 54 (6): 1273–85. PMID 21236312. doi:10.1016/j.jhep.2010.09.040

espacenet.com

worldwide.espacenet.com

Patente EP 0318216: Houghton, M; Choo, Q-L e Kuo, G, "NANBV diagnostics", publicada em 31 de Maio de 1989, atribuída a Chiron

eurosurveillance.org

Eurosurveillance editorial, team (28 de julho de 2011). «World Hepatitis Day 2011» (PDF). Eurosurveillance. 16 (30). PMID 21813077

expert-reviews.com

Halliday, J; Klenerman P, Barnes E (Maio de 2011). «Vaccination for hepatitis C virus: closing in on an evasive target» (PDF). Expert review of vaccines. 10 (5): 659–72. PMC 3112461. PMID 21604986. doi:10.1586/erv.11.55

georgetown.edu

ll.georgetown.edu

Wilken, Judge. «United States Court of Appeals for the Federal Circuit». United States Court of Appeals for the Federal Circuit. Consultado em 11 de Janeiro de 2012

google.ca

books.google.ca

Shors, Teri (8 de novembro de 2011). Understanding viruses 2nd ed. Burlington, MA: Jones & Bartlett Learning. 535 páginas. ISBN 9780763785536
Chronic Hepatitis C Virus Advances in Treatment, Promise for the Future. [S.l.]: Springer Verlag. 2011. p. 4. ISBN 9781461411918
Chronic Hepatitis C Virus Advances in Treatment, Promise for the Future. [S.l.]: Springer Verlag. 2011. pp. 103–104. ISBN 9781461411918
Day RA; Paul P; Williams B;; et al. (novembro de 2009). Brunner & Suddarth's textbook of Canadian medical-surgical nursing Canadian 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins. p. 1237. ISBN 9780781799898
Sanders, Mick (2011). Mosby's Paramedic Textbook. [S.l.]: Jones & Bartlett Publishers. p. 839. ISBN 9780323072755
Colacino, Joseph M.; Heinz, Beverly A. (25 de outubro de 2004). Hepatitis prevention and treatment. [S.l.]: Springer Science & Business Media. p. 32. 246 páginas. ISBN 978-3-7643-5956-0
Boyer, JL (2001). Liver cirrhosis and its development: proceedings of the Falk Symposium 115. [S.l.]: Springer. pp. 344. ISBN 9780792387602
Zuckerman, edited by Howard Thomas, Stanley Lemon, Arie (2008). Viral Hepatitis 3rd ed. Oxford: John Wiley & Sons. 532 páginas. ISBN 9781405143882

journal-of-hepatology.eu

Houghton M (novembro de 2009). «The long and winding road leading to the identification of the hepatitis C virus». Journal of Hepatology. 51 (5): 939–48. PMID 19781804. doi:10.1016/j.jhep.2009.08.004

natap.org

Jafari, S; Copes R, Baharlou S, Etminan M, Buxton J (novembro de 2010). «Tattooing and the risk of transmission of hepatitis C: a systematic review and meta-analysis» (PDF). International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 14 (11): e928–40. PMID 20678951. doi:10.1016/j.ijid.2010.03.019

nih.gov

ncbi.nlm.nih.gov

Maheshwari, A; Thuluvath, PJ (fevereiro de 2010). «Management of acute hepatitis C». Clinics in liver disease. 14 (1): 169–76; x. PMID 20123448. doi:10.1016/j.cld.2009.11.007
Rosen, HR (23 de junho de 2011). «Clinical practice. Chronic hepatitis C infection» (PDF). The New England Journal of Medicine. 364 (25): 2429–38. PMID 21696309. doi:10.1056/NEJMcp1006613
GBD 2015 Disease and Injury Incidence and Prevalence, Collaborators. (8 de outubro de 2016). «Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.». Lancet. 388 (10053): 1545–1602. PMC 5055577. PMID 27733282. doi:10.1016/S0140-6736(16)31678-6
GBD 2015 Mortality and Causes of Death, Collaborators. (8 de outubro de 2016). «Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.». Lancet. 388 (10053): 1459–1544. PMID 27733281. doi:10.1016/S0140-6736(16)31012-1
Webster, Daniel P; Klenerman, Paul; Dusheiko, Geoffrey M (2015). «Hepatitis C». The Lancet. 385 (9973): 1124–1135. ISSN 0140-6736. PMC 4878852. PMID 25687730. doi:10.1016/S0140-6736(14)62401-6
Gravitz L. (2011). «A smouldering public-health crisis». Nature. 474 (7350): S2–4. PMID 21666731. doi:10.1038/474S2a
Mohd Hanafiah, K; Groeger, J; Flaxman, AD; Wiersma, ST (Abril de 2013). «Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence.». Hepatology (Baltimore, Md.). 57 (4): 1333–42. PMID 23172780. doi:10.1002/hep.26141
Global Burden of Disease Study 2013, Collaborators (22 de agosto de 2015). «Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.». Lancet (London, England). 386 (9995): 743–800. PMID 26063472. doi:10.1016/s0140-6736(15)60692-4
GBD 2013 Mortality and Causes of Death, Collaborators (17 de dezembro de 2014). «Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013.». Lancet. 385 (9963): 117–71. PMC 4340604. PMID 25530442. doi:10.1016/S0140-6736(14)61682-2
Houghton M (novembro de 2009). «The long and winding road leading to the identification of the hepatitis C virus». Journal of Hepatology. 51 (5): 939–48. PMID 19781804. doi:10.1016/j.jhep.2009.08.004
Maheshwari, A; Ray S; Thuluvath PJ (26 de julho de 2008). «Acute hepatitis C». Lancet. 372 (9635): 321–32. PMID 18657711. doi:10.1016/S0140-6736(08)61116-2
Wilkins, T; Malcolm JK; Raina D; Schade RR (1 de junho de 2010). «Hepatitis C: diagnosis and treatment» (PDF). American family physician. 81 (11): 1351–7. PMID 20521755
Nelson, PK; Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, Degenhardt L (13 de agosto de 2011). «Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews». Lancet. 378 (9791): 571–83. PMC 3285467. PMID 21802134. doi:10.1016/S0140-6736(11)61097-0
Mueller, S; Millonig G; Seitz HK (28 de julho de 2009). «Alcoholic liver disease and hepatitis C: a frequently underestimated combination» (PDF). World journal of gastroenterology : WJG. 15 (28): 3462–71. PMC 2715970. PMID 19630099. doi:10.3748/wjg.15.3462 ^{[ligação inativa]}
Alter, MJ (7 de maio de 2007). «Epidemiology of hepatitis C virus infection» (PDF). World journal of gastroenterology : WJG. 13 (17): 2436–41. PMID 17552026 ^{[ligação inativa]}
Ozaras, R; Tahan, V (abril de 2009). «Acute hepatitis C: prevention and treatment». Expert review of anti-infective therapy. 7 (3): 351–61. PMID 19344247. doi:10.1586/eri.09.8
Zignego, AL; Ferri, C; Pileri, SA; et al. (janeiro de 2007). «Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach». Digestive and Liver Disease. 39 (1): 2–17. PMID 16884964. doi:10.1016/j.dld.2006.06.008
Louie, KS; Micallef JM; Pimenta JM; Forssen UM (janeiro de 2011). «Prevalence of thrombocytopenia among patients with chronic hepatitis C: a systematic review». Journal of viral hepatitis. 18 (1): 1–7. PMID 20796208. doi:10.1111/j.1365-2893.2010.01366.x
Lee, MR; Shumack, S (novembro de 2005). «Prurigo nodularis: a review». The Australasian journal of dermatology. 46 (4): 211–18; quiz 219–20. PMID 16197418. doi:10.1111/j.1440-0960.2005.00187.x
Iannuzzella, F; Vaglio, A; Garini, G (maio de 2010). «Management of hepatitis C virus-related mixed cryoglobulinemia». Am. J. Med. 123 (5): 400–8. PMID 20399313. doi:10.1016/j.amjmed.2009.09.038
Sugden, PB; Cameron, B, Bull, R, White, PA, Lloyd, AR (Setembro de 2012). «Occult infection with hepatitis C virus: friend or foe?». Immunology and cell biology. 90 (8): 763–73. PMID 22546735. doi:10.1038/icb.2012.20
Carreño, V (21 de novembro de 2006). «Occult hepatitis C virus infection: a new form of hepatitis C.». World journal of gastroenterology : WJG. 12 (43): 6922–5. PMID 17109511
Carreño García, V; Nebreda, JB, Aguilar, IC, Quiroga Estévez, JA (Março de 2011). «Occult hepatitis C virus infection.». Enfermedades infecciosas y microbiologia clinica. 29 Suppl 3: 14–9. PMID 21458706. doi:10.1016/S0213-005X(11)70022-2
Pham, TN; Coffin, CS, Michalak, TI (Abril de 2010). «Occult hepatitis C virus infection: what does it mean?». Liver international : official journal of the International Association for the Study of the Liver. 30 (4): 502–11. PMID 20070513. doi:10.1111/j.1478-3231.2009.02193.x
Carreño, V; Bartolomé, J, Castillo, I, Quiroga, JA (21 de junho de 2012). «New perspectives in occult hepatitis C virus infection.». World journal of gastroenterology : WJG. 18 (23): 2887–94. PMID 22736911. doi:10.3748/wjg.v18.i23.2887
Carreño, V; Bartolomé, J; Castillo, I; Quiroga, JA (maio–junho de 2008). «Occult hepatitis B virus and hepatitis C virus infections.». Reviews in medical virology. 18 (3): 139–57. PMID 18265423. doi:10.1002/rmv.569
Scott, JD; Gretch, DR (21 de fevereiro de 2007). «Molecular diagnostics of hepatitis C virus infection: a systematic review.». JAMA: the Journal of the American Medical Association. 297 (7): 724–32. PMID 17312292. doi:10.1001/jama.297.7.724
Robinson, JL (4 de julho de 2008). «Vertical transmission of the hepatitis C virus: Current knowledge and issues». Paediatr Child Health. 13 (6): 529–534. PMC 2532905. PMID 19436425
Nakano, T; Lau, GM; Lau, GM; et al. (dezembro de 2011). «An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region». Liver Int. 32 (2): 339–45. PMID 22142261. doi:10.1111/j.1478-3231.2011.02684.x
Pondé, RA (fevereiro de 2011). «Hidden hazards of HCV transmission» (PDF). Medical microbiology and immunology. 200 (1): 7–11. PMID 20461405. doi:10.1007/s00430-010-0159-9
Xia, X; Luo J, Bai J, Yu R (outubro de 2008). «Epidemiology of HCV infection among injection drug users in China: systematic review and meta-analysis». Public health. 122 (10): 990–1003. PMID 18486955. doi:10.1016/j.puhe.2008.01.014
Imperial, JC (junho de 2010). «Chronic hepatitis C in the state prison system: insights into the problems and possible solutions». Expert review of gastroenterology & hepatology. 4 (3): 355–64. PMID 20528122. doi:10.1586/egh.10.26
Vescio, MF; Longo B, Babudieri S, Starnini G, Carbonara S, Rezza G, Monarca R (abril de 2008). «Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis». Journal of epidemiology and community health. 62 (4): 305–13. PMID 18339822. doi:10.1136/jech.2006.051599
Tohme RA, Holmberg SD (julho de 2010). «Is sexual contact a major mode of hepatitis C virus transmission?». Hepatology. 52 (4): 1497–505. PMID 20635398. doi:10.1002/hep.23808
Jafari, S; Copes R, Baharlou S, Etminan M, Buxton J (novembro de 2010). «Tattooing and the risk of transmission of hepatitis C: a systematic review and meta-analysis» (PDF). International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 14 (11): e928–40. PMID 20678951. doi:10.1016/j.ijid.2010.03.019
Lock G; Dirscherl M; Obermeier F; et al. (setembro de 2006). «Hepatitis C — contamination of toothbrushes: myth or reality?». J. Viral Hepat. 13 (9): 571–3. PMID 16907842. doi:10.1111/j.1365-2893.2006.00735.x
Lam, NC; Gotsch, PB, Langan, RC (15 de novembro de 2010). «Caring for pregnant women and newborns with hepatitis B or C» (PDF). American family physician. 82 (10): 1225–9. PMID 21121533
Mast EE (2004). «Mother-to-infant hepatitis C virus transmission and breastfeeding». Advances in Experimental Medicine and Biology. 554: 211–6. PMID 15384578
Senadhi, V (julho de 2011). «A paradigm shift in the outpatient approach to liver function tests». Southern Medical Journal. 104 (7): 521–5. PMID 21886053. doi:10.1097/SMJ.0b013e31821e8ff5
Halliday, J; Klenerman P, Barnes E (Maio de 2011). «Vaccination for hepatitis C virus: closing in on an evasive target» (PDF). Expert review of vaccines. 10 (5): 659–72. PMC 3112461. PMID 21604986. doi:10.1586/erv.11.55
Hagan, H; Pouget, ER, Des Jarlais, DC (1 de julho de 2011). «A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs». The Journal of infectious diseases. 204 (1): 74–83. PMC 3105033. PMID 21628661. doi:10.1093/infdis/jir196
Torresi, J; Johnson D, Wedemeyer H (junho de 2011). «Progress in the development of preventive and therapeutic vaccines for hepatitis C virus» (PDF). Journal of hepatology. 54 (6): 1273–85. PMID 21236312. doi:10.1016/j.jhep.2010.09.040
Ilyas, JA; Vierling, JM (agosto de 2011). «An overview of emerging therapies for the treatment of chronic hepatitis C». Clinics in liver disease. 15 (3): 515–36. PMID 21867934. doi:10.1016/j.cld.2011.05.002
Hoofnagle, JH; Sherker, AH (17 de abril de 2014). «Therapy for hepatitis C--the costs of success.». The New England Journal of Medicine. 370 (16): 1552–3. PMID 24725236. doi:10.1056/nejme1401508
Liang, TJ; Ghany, MG (16 de maio de 2013). «Current and future therapies for hepatitis C virus infection.». The New England Journal of Medicine. 368 (20): 1907–17. PMID 23675659. doi:10.1056/NEJMra1213651
Awad T, Thorlund K, Hauser G, Stimac D, Mabrouk M, Gluud C (abril de 2010). «Peginterferon alpha-2a is associated with higher sustained virological response than peginterferon alfa-2b in chronic hepatitis C: systematic review of randomized trials». Hepatology. 51 (4): 1176–84. PMID 20187106. doi:10.1002/hep.23504
Foote BS, Spooner LM, Belliveau PP (setembro de 2011). «Boceprevir: a protease inhibitor for the treatment of chronic hepatitis C». Ann Pharmacother. 45 (9): 1085–93. PMID 21828346. doi:10.1345/aph.1P744
Smith LS, Nelson M, Naik S, Woten J (maio de 2011). «Telaprevir: an NS3/4A protease inhibitor for the treatment of chronic hepatitis C». Ann Pharmacother. 45 (5): 639–48. PMID 21558488. doi:10.1345/aph.1P430
Ghany MG, Nelson DR, Strader DB, Thomas DL, Seeff LB (outubro de 2011). «An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases». Hepatology. 54 (4): 1433–44. PMC 3229841. PMID 21898493. doi:10.1002/hep.24641
Alavian SM, Tabatabaei SV (abril de 2010). «Treatment of chronic hepatitis C in polytransfused thalassaemic patients: a meta-analysis». J. Viral Hepat. 17 (4): 236–44. PMID 19638104. doi:10.1111/j.1365-2893.2009.01170.x
De Clercq, E (15 de novembro de 2013). «Dancing with chemical formulae of antivirals: A panoramic view (Part 2).». Biochemical pharmacology. 86 (10): 1397–410. PMID 24070654. doi:10.1016/j.bcp.2013.09.010
Bunchorntavakul, C; Chavalitdhamrong, D; Tanwandee, T (27 de setembro de 2013). «Hepatitis C genotype 6: A concise review and response-guided therapy proposal.». World journal of hepatology. 5 (9): 496–504. PMID 24073301. doi:10.4254/wjh.v5.i9.496
Ciria R, Pleguezuelo M, Khorsandi SE; et al. (Maio de 2013). «Strategies to reduce hepatitis C virus recurrence after liver transplantation». World J Hepatol. 5 (5): 237–50. PMC 3664282. PMID 23717735. doi:10.4254/wjh.v5.i5.237
Coilly A, Roche B, Samuel D (Fevereiro de 2013). «Current management and perspectives for HCV recurrence after liver transplantation». Liver Int. 33 Supl. 1: 56–62. PMID 23286847. doi:10.1111/liv.12062
Liu, J; Manheimer E, Tsutani K, Gluud C (março de 2003). «Medicinal herbs for hepatitis C virus infection: a Cochrane hepatobiliary systematic review of randomized trials». The American journal of gastroenterology. 98 (3): 538–44. PMID 12650784. doi:10.1111/j.1572-0241.2003.07298.x
Rambaldi, A; Jacobs, BP; Gluud, C (17 de Outubro de 2007). «Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases». Cochrane Database Syst Rev (4): CD003620. PMID 17943794
Fung J; Lai CL; Hung I; et al. (Setembro de 2008). «Chronic hepatitis C virus genotype 6 infection: response to pegylated interferon and ribavirin». The Journal of Infectious Diseases. 198 (6): 808–12. PMID 18657036. doi:10.1086/591252
Yu ML; Chuang WL (março de 2009). «Treatment of chronic hepatitis C in Asia: when East meets West». J. Gastroenterol. Hepatol. 24 (3): 336–45. PMID 19335784. doi:10.1111/j.1440-1746.2009.05789.x
Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (abril de 1989). «Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome». Science. 244 (4902): 359–62. PMID 2523562. doi:10.1126/science.2523562
Kuo, G; Choo, Q L; Alter, H J; et al. (21 de abril de 1989). «An Assay for Circulating Antibodies to a Major Etiologic Virus of Human non-A, non-B Hepatitis». Science. 244 (4902): 362–4. PMID 2496467. doi:10.1126/science.2496467. Consultado em 3 de junho de 2020
Eurosurveillance editorial, team (28 de julho de 2011). «World Hepatitis Day 2011» (PDF). Eurosurveillance. 16 (30). PMID 21813077
Wong, JB (2006). «Hepatitis C: cost of illness and considerations for the economic evaluation of antiviral therapies». PharmacoEconomics. 24 (7): 661–72. PMID 16802842. doi:10.2165/00019053-200624070-00005
El Khoury, AC; Klimack, WK; Wallace, C; Razavi, H (1 de Dezembro de 2011). «Economic burden of hepatitis C-associated diseases in the United States». Journal of Viral Hepatitis. 19 (3): 153–60. PMID 22329369. doi:10.1111/j.1365-2893.2011.01563.x
Ahn, J; Flamm, SL (agosto de 2011). «Hepatitis C therapy: other players in the game». Clinics in liver disease. 15 (3): 641–56. PMID 21867942. doi:10.1016/j.cld.2011.05.008
Vermehren, J; Sarrazin, C (fevereiro de 2011). «New HCV therapies on the horizon». Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 17 (2): 122–34. PMID 21087349. doi:10.1111/j.1469-0691.2010.03430.x

niddk.nih.gov

«Viral Hepatitis: A through E and Beyond». National Institute of Diabetes and Digestive and Kidney Diseases. Abril de 2012. Consultado em 4 de fevereiro de 2016

nccam.nih.gov

Hepatitis C and CAM: What the Science Says Arquivado em 20 de março de 2011, no Wayback Machine.. National Center for Complementary and Alternative Medicine (NCCAM). Março de 2011.

pubmed.ncbi.nlm.nih.gov

Kuo, G; Choo, Q L; Alter, H J; et al. (21 de abril de 1989). «An Assay for Circulating Antibodies to a Major Etiologic Virus of Human non-A, non-B Hepatitis». Science. 244 (4902): 362–4. PMID 2496467. doi:10.1126/science.2496467. Consultado em 3 de junho de 2020

oxfordjournals.org

jid.oxfordjournals.org

Hagan, H; Pouget, ER, Des Jarlais, DC (1 de julho de 2011). «A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs». The Journal of infectious diseases. 204 (1): 74–83. PMC 3105033. PMID 21628661. doi:10.1093/infdis/jir196
Fung J; Lai CL; Hung I; et al. (Setembro de 2008). «Chronic hepatitis C virus genotype 6 infection: response to pegylated interferon and ribavirin». The Journal of Infectious Diseases. 198 (6): 808–12. PMID 18657036. doi:10.1086/591252

phac-aspc.gc.ca

«Hepatitis C Prevention, Support and Research ProgramHealth Canada». Public Health Agency of Canada. Novembro de 2003. Consultado em 10 de Janeiro de 2012

springerlink.com

Pondé, RA (fevereiro de 2011). «Hidden hazards of HCV transmission» (PDF). Medical microbiology and immunology. 200 (1): 7–11. PMID 20461405. doi:10.1007/s00430-010-0159-9

va.gov

hepatitis.va.gov

«Hepatitis C Group Education Class». United States Department of Veteran Affairs

web.archive.org

Hepatitis C and CAM: What the Science Says Arquivado em 20 de março de 2011, no Wayback Machine.. National Center for Complementary and Alternative Medicine (NCCAM). Março de 2011.
Winners Albert Lasker Award for Clinical Medical Research, The Lasker Foundation. Retrieved 20 Fevereiro 2008.

who.int

«Hepatitis C Fact sheet N°164». WHO. Julho de 2015. Consultado em 4 de fevereiro de 2016
«Hepatitis C». World Health Organization (WHO). Junho de 2011. Consultado em 13 de julho de 2011

wiley.com

onlinelibrary.wiley.com

Tohme RA, Holmberg SD (julho de 2010). «Is sexual contact a major mode of hepatitis C virus transmission?». Hepatology. 52 (4): 1497–505. PMID 20635398. doi:10.1002/hep.23808
Awad T, Thorlund K, Hauser G, Stimac D, Mabrouk M, Gluud C (abril de 2010). «Peginterferon alpha-2a is associated with higher sustained virological response than peginterferon alfa-2b in chronic hepatitis C: systematic review of randomized trials». Hepatology. 51 (4): 1176–84. PMID 20187106. doi:10.1002/hep.23504
Ghany MG, Nelson DR, Strader DB, Thomas DL, Seeff LB (outubro de 2011). «An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases». Hepatology. 54 (4): 1433–44. PMC 3229841. PMID 21898493. doi:10.1002/hep.24641
Yu ML; Chuang WL (março de 2009). «Treatment of chronic hepatitis C in Asia: when East meets West». J. Gastroenterol. Hepatol. 24 (3): 336–45. PMID 19335784. doi:10.1111/j.1440-1746.2009.05789.x
Vermehren, J; Sarrazin, C (fevereiro de 2011). «New HCV therapies on the horizon». Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 17 (2): 122–34. PMID 21087349. doi:10.1111/j.1469-0691.2010.03430.x

wjgnet.com

Mueller, S; Millonig G; Seitz HK (28 de julho de 2009). «Alcoholic liver disease and hepatitis C: a frequently underestimated combination» (PDF). World journal of gastroenterology : WJG. 15 (28): 3462–71. PMC 2715970. PMID 19630099. doi:10.3748/wjg.15.3462 ^{[ligação inativa]}
Alter, MJ (7 de maio de 2007). «Epidemiology of hepatitis C virus infection» (PDF). World journal of gastroenterology : WJG. 13 (17): 2436–41. PMID 17552026 ^{[ligação inativa]}

worldcat.org

Webster, Daniel P; Klenerman, Paul; Dusheiko, Geoffrey M (2015). «Hepatitis C». The Lancet. 385 (9973): 1124–1135. ISSN 0140-6736. PMC 4878852. PMID 25687730. doi:10.1016/S0140-6736(14)62401-6